Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Estrella ImmunopharmaESLA -1.11%12 Dividend Payout Ratio is 0.00 as of Jun. 2026. GuruFocus rates ESLA with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 128 Biotechnology companies, Estrella Immunopharma ranks worse than 781249.22% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Estrella Immunopharma's Dividend Payout Ratio for the
months ended in Jun. 2026 was 0.00.
The historical rank and industry rank for Estrella Immunopharma's Dividend Payout Ratio or its related term are showing as below:
ESLA's Dividend Payout Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 0.445 * Ranked among companies with meaningful Dividend Payout Ratio only.
Estrella Immunopharma (NAS:ESLA) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Estrella Immunopharma Dividend Payout Ratio Related Terms
Estrella Immunopharma Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Estrella Immunopharma's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ESLA vs LITS, NNVC, LTRN: Dividend Payout Ratio Comparison
For the Biotechnology subindustry, Estrella Immunopharma's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Estrella Immunopharma Dividend Payout Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Estrella Immunopharma's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Estrella Immunopharma's Dividend Payout Ratio falls into.
Estrella Immunopharma Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Estrella Immunopharma's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Estrella Immunopharma (ESLA) has a Dividend Payout Ratio of 0.00 as of Jun. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Estrella Immunopharma and its competitors. According to the industry distribution chart, Estrella Immunopharma ranks #999999 out of 128 companies in the Biotechnology industry.
Is Estrella Immunopharma's Dividend Payout Ratio too high?
Estrella Immunopharma's current Dividend Payout Ratio is 0.00. Based on the distribution chart, Estrella Immunopharma ranks #999999 out of 128 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Estrella Immunopharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Estrella Immunopharma's Dividend Payout Ratio compare to LITS and NNVC?
According to the Biotechnology industry distribution chart, Estrella Immunopharma ranks #999999 out of 128 companies for Dividend Payout Ratio. This places Estrella Immunopharma in the lower half of its industry. The industry median Dividend Payout Ratio is 0.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.45, based on 128 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Estrella Immunopharma and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Estrella Immunopharma's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Estrella Immunopharma stock overvalued right now?
Estrella Immunopharma (ESLA) has a current Dividend Payout Ratio of 0.00. The current Dividend Payout Ratio is 0.00. Estrella Immunopharma's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Estrella Immunopharma (ESLA), the current Dividend Payout Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
12GF Score
Get the complete analysis for ESLA
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESLA has been successfully added to your 
